Programs




Expert discussion about the rapidly evolving treatment landscape in myeloma featuring Amrita Krishnan, MD, FACP, and Craig Cole, MD.





Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2015 American Society of Hematology (ASH) Annual Meeting. This program offers continuing medical education credits for physicians.





Through a presentation of case studies, best practices for patient management are shared. Important themes are highlighted throughout each case, including treatment, side effect management, and effective communication tools for educating patients on clinical trials. The 1.5 hour program includes four cases - two presented at the live symposium at ONS and two recorded after the live program by our expert panel. The 1.0 hour program includes two case studies.





Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting and the 20th Congress of the European Hematology Association (EHA). This program offers continuing medical education credits for physicians.





Listen to our panel of experts discuss some of the latest breakthrough treatments in multiple myeloma as presented at the 2014 American Society of Hematology (ASH) Annual Meeting in Orlando, FL.




Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2014 American Society of Hematology (ASH) Annual Meeting in Orlando, FL. This program offers continuing medical education credits for physicians.




Listen to our panel of experts discuss some of the latest breakthrough treatments in multiple myeloma as presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, and the 19th Congress of the European Hematology Association (EHA) in Milan, Italy.




Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. This program offers continuing medical education credits for physicians.




We invite you to watch this progam to learn more about:
  •  Tips for planning discussions with your healthcare team about treatment decisions
  •  Working with an Information Specialist at The Leukemia & Lymphoma Society (LLS) to obtain personalized information and guidance
  •  Strengthening communication with your healthcare team
  •  Coping with the challenges of a non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL) diagnosis
  •  Finding additional resources to support you on your cancer journey




Listen to our panel of experts discuss some of the latest breakthrough treatments in multiple myeloma as presented at the 2013 American Society of Hematology (ASH) Annual Meeting in New Orleans, LA.




Clinical Insights in Multiple Myeloma, November 2013 – This program features co-chairs Joseph Mikhael, MD, MEd, FRCP, FACP, and
A. Keith Stewart, MBChB, from the Mayo Clinic in Scottsdale, AZ, who discuss key topics in the treatment of patients with multiple myeloma including prognosis and risk, treatment options for newly diagnosed patients, stem cell transplantation, treating relapsed/refractory disease, supportive therapies, and clinical trials.




Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2013 American Society of Hematology (ASH) Annual Meeting in New Orleans, LA. This program offers continuing education credits for physicians.




We invite you to watch this progam to learn more about:
  •  Non-Hodgkin lymphoma (NHL) treatment, monitoring, and side effects management
  •  NHL survivorship
  •  Communicating with your healthcare team
  •  Managing long-term and late effects





Clinical Insights in Multiple Myeloma, June 2013 – This program features co-chairs Kenneth C. Anderson, MD, and Paul G. Richardson, MD, from Dana-Farber Cancer Institute in Boston, MA, who discuss key topics in the treatment of patients with multiple myeloma including treatments for newly diagnosed patients, stem cell transplantation, relapsed/refractory treatments, supportive care options, and clinical trials.




Listen to experts in multiple myeloma discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.




Listen to our panel of experts discuss some of the latest breakthrough treatments in multiple myeloma as presented at the 14th International Myeloma Workshop in Kyoto, Japan.




Learn about some of the latest breakthrough treatments in multiple myeloma such as Pomalyst® (pomalidomide), Kyprolis™ (carfilzomib), and subcutaneous Velcade® (bortezomib) from our panel of experts.




Watch as Michael Needle, MD, Chief Medical Officer, Multiple Myeloma Research Foundation, discusses the most recent FDA-approved treatment for multiple myeloma – Kyprolis™ (carfilzomib) – with esteemed medical professionals, Sundar Jagannath, MD, and Donna D. Catamero, ANP-BC, OCN, CCRC, from the Tisch Cancer Institute at the Mount Sinai Health System.




The Lymphoma Research Foundation's Lymphoma Workshop provides the latest information about lymphoma, current treatment options, and information about living with the disease.




Learn about managing fatigue, anxiety, depression, and pain through the experiences of Laura and Todd, with insights from their healthcare professionals, Edward Stadtmauer, MD, Patricia Mangan, CRNP, and Lissa Parsonnet, PhD.